John W. Lippert

645 total citations
13 papers, 562 citations indexed

About

John W. Lippert is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, John W. Lippert has authored 13 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in John W. Lippert's work include Synthesis and biological activity (7 papers), Click Chemistry and Applications (6 papers) and Synthetic Organic Chemistry Methods (3 papers). John W. Lippert is often cited by papers focused on Synthesis and biological activity (7 papers), Click Chemistry and Applications (6 papers) and Synthetic Organic Chemistry Methods (3 papers). John W. Lippert collaborates with scholars based in United States and United Kingdom. John W. Lippert's co-authors include George R. Pettit, Delbert L. Herald, Steven D. Shnyder, Patricia A. Cooper, Paul M. Loadman, Alan Anthoney, David J. Swaine, M C Bibby, Ernest Hamel and Robin K. Pettit and has published in prestigious journals such as Clinical Cancer Research, The Journal of Organic Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

John W. Lippert

13 papers receiving 552 citations

Peers

John W. Lippert
John W. Lippert
Citations per year, relative to John W. Lippert John W. Lippert (= 1×) peers Yukio Nihei

Countries citing papers authored by John W. Lippert

Since Specialization
Citations

This map shows the geographic impact of John W. Lippert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Lippert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Lippert more than expected).

Fields of papers citing papers by John W. Lippert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. Lippert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Lippert. The network helps show where John W. Lippert may publish in the future.

Co-authorship network of co-authors of John W. Lippert

This figure shows the co-authorship network connecting the top 25 collaborators of John W. Lippert. A scholar is included among the top collaborators of John W. Lippert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John W. Lippert. John W. Lippert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lippert, John W.. (2016). The Combretastins A-1 and A-4 Prodrugs: A Mini-Review. Journal of Analytical & Pharmaceutical Research. 3(1). 1 indexed citations
2.
Tanpure, Rajendra P., Tracy E. Strecker, Sanjeev Sharma, et al.. (2011). Regioselective Synthesis of Water-Soluble Monophosphate Derivatives of Combretastatin A-1. Journal of Natural Products. 74(7). 1568–1574. 11 indexed citations
3.
Barnes, Keith D., et al.. (2010). Lactam Coupling as a Versatile Route to Indoprofen Analogs. Synthetic Communications. 41(1). 67–72. 1 indexed citations
4.
Lippert, John W.. (2007). Vascular Disrupting Agents. ChemInform. 38(17). 3 indexed citations
5.
Lippert, John W.. (2006). Vascular disrupting agents. Bioorganic & Medicinal Chemistry. 15(2). 605–615. 219 indexed citations
6.
Loadman, Paul M., David J. Swaine, Alan Anthoney, et al.. (2004). Comparative Preclinical Pharmacokinetic and Metabolic Studies of the Combretastatin Prodrugs Combretastatin A4 Phosphate and A1 Phosphate. Clinical Cancer Research. 10(4). 1446–1453. 85 indexed citations
7.
Shnyder, Steven D., Patricia A. Cooper, George R. Pettit, John W. Lippert, & M C Bibby. (2003). Combretastatin A-1 phosphate potentiates the antitumour activity of cisplatin in a murine adenocarcinoma model.. PubMed. 23(2B). 1619–23. 19 indexed citations
8.
Holwell, S E, Patricia A. Cooper, Konstantina Grosios, et al.. (2002). Combretastatin A-1 phosphate a novel tubulin-binding agent with in vivo anti vascular effects in experimental tumours.. PubMed. 22(2A). 707–11. 35 indexed citations
9.
Pettit, George R., John W. Lippert, Stuart R. Taylor, Rui Tan, & Michael D. Williams. (2001). Synthesis of Phakellistatin 11:  A Micronesia (Chuuk) Marine Sponge Cyclooctapeptide. Journal of Natural Products. 64(7). 883–891. 28 indexed citations
10.
Pettit, George R., John W. Lippert, & Delbert L. Herald. (2000). A Pinacol Rearrangement/Oxidation Synthetic Route to Hydroxyphenstatin1. The Journal of Organic Chemistry. 65(22). 7438–7444. 42 indexed citations
11.
Pettit, George R. & John W. Lippert. (2000). Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugs.. PubMed. 15(3). 203–16. 78 indexed citations
12.
Pettit, George R., John W. Lippert, Delbert L. Herald, Ernest Hamel, & Robin K. Pettit. (2000). Antineoplastic Agents 440. Asymmetric Synthesis and Evaluation of the Combretastatin A-1 SAR Probes (1S,2S)- and (1R,2R)-1,2-Dihydroxy- 1-(2‘,3‘-dihydroxy-4‘-methoxyphenyl)-2-(3‘ ‘,4‘ ‘,5‘ ‘-trimethoxyphenyl)-ethane. Journal of Natural Products. 63(7). 969–974. 35 indexed citations
13.
Pettit, George R., John W. Lippert, Michael R. Boyd, Pascal Verdier‐Pinard, & Ernest Hamel. (2000). Antineoplastic agents 442. Synthesis and biological activities of dioxostatin.. PubMed. 15(5). 361–71. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026